Search results for "Rini"

showing 10 items of 746 documents

Switching between persistent firing and depolarization block in individual rat CA1 pyramidal neurons

2018

The hippocampal formation plays a role in mnemonic tasks and epileptic discharges in vivo. In vitro, these functions and malfunctions may relate to persistent firing (PF) and depolarization block (DB), respectively. Pyramidal neurons of the CA1 field have previously been reported to engage in either PF or DB during cholinergic stimulation. However, it is unknown whether these cells constitute disparate populations of neurons. Furthermore, it is unclear which cell-specific peculiarities may mediate their diverse response properties. However, it has not been shown whether individual CA1 pyramidal neurons can switch between PF and DB states. Here, we used whole cell patch clamp in the current …

MalePotassium ChannelsPatch-Clamp Techniquesantagonists & inhibitors [TRPC Cation Channels]physiology [Electrophysiological Phenomena]Cognitive Neurosciencepharmacology [Muscarinic Agonists]metabolism [TRPC Cation Channels]drug effects [Pyramidal Cells]HippocampusStimulationMuscarinic AgonistsIn Vitro TechniquesHippocampal formation050105 experimental psychologyMembrane Potentialspharmacology [Carbachol]03 medical and health sciences0302 clinical medicineCurrent clampAnimalsRats Long-Evans0501 psychology and cognitive sciencesddc:610Patch clampCA1 Region HippocampalTRPC Cation Channelsphysiology [CA1 Region Hippocampal]Dose-Response Relationship Drugphysiology [Pyramidal Cells]ChemistryPyramidal Cells05 social sciencescytology [CA1 Region Hippocampal]drug effects [Membrane Potentials]Depolarizationmetabolism [Potassium Channels]drug effects [Electrophysiological Phenomena]Potassium channelElectrophysiological PhenomenaRatsdrug effects [CA1 Region Hippocampal]CholinergicCarbacholFemaleNeuroscience030217 neurology & neurosurgeryHippocampus
researchProduct

Indacaterol vs tiotropium in COPD patients classified as GOLD A and B

2015

SummaryIntroductionAccording to current GOLD strategy, patients with COPD classified as groups A and B may be treated with inhaled bronchodilators, either long-acting β2-agonist (LABA) or long-acting muscarinic antagonist (LAMA). However, there is little guidance on which class of agent is preferred and a lack of prospective data to differentiate the two.MethodsIn this study, we performed post-hoc analyses of pooled data from two prospective, controlled clinical trials comparing the LABA indacaterol and LAMA tiotropium in 1422 patients with moderate airflow limitation and no history of exacerbations in the previous year. This population fits the definitions of GOLD A and B groups and could …

MalePulmonary and Respiratory MedicineEfficacyPopulationINDEXESQuinolonesOBSTRUCTIVE PULMONARY-DISEASEPulmonary Disease Chronic ObstructiveHumansMedicineCOPDCOHORTProspective StudiesGOLDTiotropium BromideeducationDYSPNEAIndacateroleducation.field_of_studyCOPDDose-Response Relationship Drugbiologybusiness.industryTiotropiumONCE-DAILY INDACATEROLMuscarinic antagonistForced Expiratory Flow RatesBaseline Dyspnea IndexMiddle AgedLamabiology.organism_classificationmedicine.diseaseBronchodilator Agentsrespiratory tract diseasesClinical trialTreatment OutcomeAnesthesiaIndansCohortIndacaterolFemalebusinessCLINICAL METHODSFollow-Up Studiesmedicine.drugRespiratory Medicine
researchProduct

Muscarinic Control of Histamine Release from Airways

2000

Isolated human bronchi and rat tracheae were incubated in organ baths to measure histamine release. The calcium ionophore A23187, 3 micromol/L in rat trachea and 10 micromol/L in human bronchi, stimulated histamine release by 145 +/- 50% (n = 6) and 270 +/- 48% (n = 7) above the prestimulation level, respectively. Acetylcholine (100 pmol/L; human bronchi) or oxotremorine (1, 100, 10,000 nmol/L; rat trachea) did not affect the spontaneous histamine release. In rat tracheae neither acetylcholine nor oxotremorine inhibited A23187-evoked histamine release, whereas 100 pmol/L acetylcholine significantly suppressed the evoked histamine release in human bronchi by 86%. For receptor characterizatio…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyBronchiMuscarinic AntagonistsBiologyCritical Care and Intensive Care MedicineHistamine ReleaseRats Sprague-Dawleychemistry.chemical_compoundOrgan Culture TechniquesPiperidinesSpecies SpecificityInternal medicineMuscarinic acetylcholine receptormedicineOxotremorineAnimalsHumansMast CellsClozapineCalcimycinIonophoresOxotremorineParasympatholyticsPirenzepineMuscarinic acetylcholine receptor M1respiratory systemMast cellReceptors MuscarinicPirenzepineAcetylcholineRatsTracheaEndocrinologymedicine.anatomical_structurechemistryFemaleHistamineAcetylcholineRespiratory tractmedicine.drugAmerican Journal of Respiratory and Critical Care Medicine
researchProduct

GOLD 2017 treatment pathways in ‘real life’: An analysis of the DACCORD observational study

2017

Abstract Introduction The 2017 update to the Global Initiative for Obstructive Lung Disease (GOLD) strategy document includes recommendations for treatment intensification or step-down in chronic obstructive pulmonary disease (COPD), although recognises that limited supporting information is available. DACCORD is an ongoing observational, non-interventional study, recruiting patients following COPD maintenance treatment change or initiation, a subset of whom were receiving a long-acting β2-agonist (LABA) plus a long-acting muscarinic antagonist (LAMA) fixed-dose combination (FDC) on entry. Since there were no requirements in terms of prior medication (and no washout before commencing LABA/L…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyExacerbationmedicine.drug_classMuscarinic AntagonistsQuinolonesMaintenance ChemotherapyPulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicinePharmacotherapyAdrenal Cortex HormonesGermanyInternal medicineAdministration InhalationmedicineHumansddc:610Longitudinal StudiesProspective Studies030212 general & internal medicineAdrenergic beta-2 Receptor AgonistsAgedCOPDbiologybusiness.industryDisease ManagementMiddle AgedLamabiology.organism_classificationmedicine.diseaseGlycopyrrolateObstructive lung diseaseDrug Combinations030228 respiratory systemIndansPractice Guidelines as TopicCritical PathwaysDisease ProgressionPhysical therapyIndacaterolCorticosteroidDrug Therapy CombinationFemaleObservational studybusinesshormones hormone substitutes and hormone antagonistsmedicine.drugRespiratory Medicine
researchProduct

Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease

2016

Abstract Background Long-term safety, particularly cardiovascular safety, is of special interest in maintenance treatment of chronic obstructive pulmonary disease (COPD) with long-acting β 2 -agonists and long-acting muscarinic antagonists, given potential cardiovascular effects. Methods Two 52-week Phase III trials (TONADO ® ) investigated tiotropium/olodaterol (5/5 and 2.5/5 μg) versus tiotropium 2.5, 5 μg and olodaterol 5 μg. In a pre-specified safety analysis, investigator-reported treatment-emergent adverse events (AEs), electrocardiogram and laboratory data were pooled. All serious AE (SAE) reports were reviewed by an independent Adjudication Committee, which assessed whether deaths, …

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyMedDRAComorbidityMuscarinic AntagonistsPulmonary Disease Chronic Obstructive03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDouble-Blind MethodForced Expiratory VolumeInternal medicineAdministration InhalationmedicineHumans030212 general & internal medicineTiotropium BromideAdverse effectAdrenergic beta-2 Receptor AgonistsAgedCOPDbusiness.industryIncidenceIncidence (epidemiology)OlodaterolTiotropium bromideMiddle Agedmedicine.diseaseComorbidityBenzoxazinesBronchodilator AgentsDrug Combinations030228 respiratory systemchemistryCardiovascular DiseasesAnesthesiaFemalebusinessMaceFollow-Up Studiesmedicine.drug
researchProduct

In vitro anti-inflammatory effects of AZD8999, a novel bifunctional muscarinic acetylcholine receptor antagonist /β2-adrenoceptor agonist (MABA) comp…

2019

Recent evidence indicates that AZD8999 (LAS190792), a novel muscarinic acetylcholine receptor antagonist and β2-adrenoceptor agonist (MABA) in development for chronic respiratory diseases, induces potent and sustained relaxant effects in human bronchi by adressing both muscarinic acetylcholine receptors and β2-adrenoceptor. However, the anti-inflammatory effects of the AZD8999 monotherapy or in combination with corticosteroids are unknown. This study investigates the anti-inflammatory effects of AZD8999 in monotherapy and combined with fluticasone propionate in neutrophils from healthy and chronic obstructive pulmonary disease (COPD) patients. Peripheral blood neutrophils from healthy and C…

MalePulmonologyNeutrophilsPhysiologyAnti-Inflammatory AgentsPharmacologyPathology and Laboratory MedicineBiochemistryPulmonary Disease Chronic ObstructiveWhite Blood CellsGlucocorticoid receptorAnimal CellsMuscarinic acetylcholine receptorMedicine and Health SciencesPost-Translational ModificationPhosphorylationReceptorImmune ResponseMultidisciplinaryPharmaceuticsQRDrug SynergismMiddle AgedReceptors MuscarinicHealthy VolunteersBody FluidsChemistryBloodPhysical SciencesQuinolinesMedicineDrug Therapy CombinationFemalemedicine.symptomCellular TypesAnatomymedicine.drugResearch ArticleSignal TransductionAgonistTransmembrane Receptorsmedicine.drug_classp38 mitogen-activated protein kinasesChronic Obstructive Pulmonary DiseaseImmune CellsScienceImmunologyInflammationMuscarinic AntagonistsThiophenesFluticasone propionateSigns and SymptomsDrug TherapyCyclohexanesDiagnostic MedicinemedicineHumansAdrenergic beta-2 Receptor AgonistsAgedInflammationBlood CellsDose-Response Relationship Drugbusiness.industryAntagonistChemical CompoundsBiology and Life SciencesProteinsCell BiologyAcetylcholine ReceptorsFluticasoneMuscarinic Acetylcholine ReceptorsReceptors Adrenergic beta-2PropionatesbusinessReceptor Antagonist TherapyPLoS ONE
researchProduct

Synthesis and Muscarinic Activity of Isoxazole-substituted 1,2,5,6-Tetrahydropyridines

1994

MalePyridinesGuinea PigsCholinergic AgentsPharmaceutical ScienceMuscarinic acetylcholine receptor M3Muscle SmoothMuscarinic acetylcholine receptor M2Biological activityIsoxazolesMuscarinic acetylcholine receptor M1In Vitro Techniqueschemistry.chemical_compoundchemistryBiochemistryDrug DiscoveryMuscarinic acetylcholine receptorMuscarinic acetylcholine receptor M5Muscarinic acetylcholine receptor M4AnimalsRabbitsIsoxazoleMuscle ContractionArchiv der Pharmazie
researchProduct

Affinity and efficacy of racemic, (+)-, and (−)-methacholine in muscarinic inhibition of [3H]-noradrenaline release

1985

The right postganglionic sympathetic nerves of rat isolated perfused hearts (previously loaded with [3H]-noradrenaline) were stimulated electrically with 10 trains of 10 pulses at 10 Hz. The inhibition by methacholine of stimulation-evoked [3H]-noradrenaline overflow into the perfusate (determined in the presence of corticosterone, desipramine, phentolamine, and propranolol) was taken as a measure for activation of presynaptic muscarinic receptors. The evoked [3H]-noradrenaline overflow was inhibited by (+)-, racemic, and (-)-methacholine in a reversible and concentration-dependent manner. The concentration causing 50% inhibition (IC50) was 0.1, 0.26, and 65 microM, respectively, resulting …

MaleReceptor complexSympathetic Nervous SystemIntrinsic activityPhenoxybenzamineStereochemistryPhysostigminePropranololIn Vitro TechniquesPropylbenzilylcholine MustardNorepinephrineMuscarinic acetylcholine receptormedicineAnimalsMethacholine CompoundsDrug InteractionsReceptorMethacholine ChlorideNeuronsPharmacologyPhenoxybenzamineChemistryHeartRats Inbred StrainsStereoisomerismReceptors MuscarinicElectric StimulationRatsDissociation constantSynapsesMethacholineCorticosteroneResearch Articlemedicine.drugBritish Journal of Pharmacology
researchProduct

Factors affecting the intensity of epidermal papillomatosis in populations of roach, Rutilus rutilus (L.), estimated as scale coverage

2006

Studies of epidermal papillomatosis in fish populations have only rarely focused on the intensity of the disease, i.e. the number and size of papillomas. Furthermore, the methods used to evaluate the intensity of papillomatosis have not been standardized. We tested the reliability of a method based on counting of scales covered by papilloma tumours in roach, Rutilus rutilus (L). In addition, we studied the frequency distributions of the number of scales covered by papillomas within populations, evaluated the correlation between the prevalence and mean intensity of the disease among populations and examined the intensity of papillomatosis in roach with respect to sex and size of fish. Reliab…

MaleScale (anatomy)Veterinary medicineSkin NeoplasmsVeterinary (miscellaneous)CyprinidaeFish speciesFresh WaterPapillomatosisAquatic ScienceFish DiseasesSex FactorsPrevalencemedicineAnimalsBody SizeFinlandPapillomabiologyEcologybiology.organism_classificationIntensity (physics)Fish <Actinopterygii>FemaleEpidermisRutilusmedicine.symptomJournal of Fish Diseases
researchProduct

Adrenoceptor- and cholinoceptor-mediated mechanisms in the regulation of 5-hydroxytryptamine release from isolated tracheae of newborn rabbits

1996

Abstract 1. Isolated tracheae of newborn rabbits were incubated in vitro and the outflow of 5-hydroxytryptamine (5-HT) was determined by h.p.l.c. with electrochemical detection. Evidence has previously been provided that this 5-HT outflow derives from neuroendocrine epithelial (NEE) cells of the airway mucosa. 2. Phenylephrine (1, 10 and 30 microM) enhanced the outflow of 5-HT by 80, 290 and 205%, respectively. 5-HT outflow evoked by 10 microM phenylephrine was not affected by the presence of the neurotoxin tetrodotoxin (1 microM). 3. Rauwolscine, ARC 239 (an alpha(2B)-adrenoceptor preferring antagonist), yohimbine and prazosin antagonized the effect of 10 microM phenylephrine in a concentr…

MaleSerotoninmedicine.medical_specialtyRauwolscineIn Vitro TechniquesMuscarinic Agonistschemistry.chemical_compoundIsoprenalineInternal medicineReceptors Adrenergic betaCyclic AMPmedicinePrazosinAnimalsReceptors CholinergicPhenylephrinePharmacologyForskolinMuscarineHydroxyindoleacetic AcidReceptors AdrenergicYohimbineTracheaEndocrinologyAnimals NewbornchemistryFemaleHexamethoniumRabbitsResearch Articlemedicine.drugBritish Journal of Pharmacology
researchProduct